Skip to main content

CITADEL ADVISORS LLC

Position in CNTA — Centessa Pharmaceuticals plc

CIK 1423053 MIAMI, FL

Position in CNTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
598,197
+15.0% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Derivatives in CNTA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
83,600
PutValue
$0
PutShares
48,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-03-31 598,197
2026-03-31 83,600
2026-03-31 48,200
2025-12-31 37,400
2025-12-31 519,962
2025-12-31 22,500
2025-09-30 31,600
2025-09-30 95,000
2025-09-30 137,201
2025-06-30 35,500
2025-06-30 40,000
2025-03-31 17,200
2025-03-31 706,331
2025-03-31 17,100
2024-12-31 400
2024-12-31 7,000
2024-12-31 625,316
2024-09-30 5,900
2024-09-30 587,518
2024-09-30 29,500
2024-06-30 3,000
2024-06-30 38,276
2024-06-30 12,100
2024-03-31 5,000
2024-03-31 46,968
2024-03-31 17,700
2023-12-31 100,804
2023-12-31 4,000
2023-12-31 9,600
2023-09-30 2,100
2023-09-30 7,000
2023-09-30 3,019
2023-06-30 4,105
2023-06-30 1,200
2023-06-30 5,300
2022-12-31 72,307
2022-12-31 1,000
2022-09-30 225,368
2022-06-30 290,583
2022-03-31 304,426
2021-12-31 340,065
2021-09-30 349,548
2021-06-30 456,233